​

MiNK Therapeutics (INKT) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

INKT Stock Forecast

MiNK Therapeutics (INKT) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $35.00, with a high of $35.00 and a low of $35.00. This represents a 146.48% increase from the last price of $14.20.

- $7 $14 $21 $28 $35 High: $35 Avg: $35 Low: $35 Last Closed Price: $14.2

INKT Stock Rating

MiNK Therapeutics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

INKT Price Target Upside V Benchmarks

TypeNameUpside
StockMiNK Therapeutics146.48%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$35.00
Last Closing Price$14.20$14.20$14.20
Upside/Downside--146.48%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2511---2
Sep, 2511---2
Aug, 25-12--3
Jul, 2512---3
Jun, 2512---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 15, 2025Emily BodnarH.C. Wainwright$35.00$28.7521.74%146.48%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2025H.C. WainwrightNeutralBuyupgrade
Jul 15, 2025H.C. WainwrightNeutraldowngrade
Jul 11, 2025William BlairMarket Performdowngrade

Financial Forecast

EPS Forecast

$-300 $-230 $-160 $-90 $-20 $50 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.65$-285.82----
Avg Forecast$-6.51$-3.65$-2.71$-2.86$-2.70$2.40
High Forecast$-6.31$-3.58$-2.32$-2.61$-2.50$2.40
Low Forecast$-6.71$-3.71$-3.10$-3.11$-2.90$2.40
Surprise %-90.02%7730.68%----

Revenue Forecast

$0 $15M $30M $45M $60M $75M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$4.40M$70.40M
High Forecast----$4.40M$70.40M
Low Forecast----$4.40M$70.40M
Surprise %------

Net Income Forecast

$-15B $-11B $-7B $-3B $1B $5B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-22.46M$-10.78B----
Avg Forecast$-223.67M$-125.29M$-93.17M$-98.18M$-92.77M$82.46M
High Forecast$-216.79M$-123.02M$-79.86M$-89.57M$-85.90M$82.46M
Low Forecast$-230.55M$-127.57M$-106.48M$-106.80M$-99.64M$82.46M
Surprise %-89.96%8507.63%----

INKT Forecast FAQ

Is MiNK Therapeutics stock a buy?

MiNK Therapeutics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MiNK Therapeutics is a favorable investment for most analysts.

What is MiNK Therapeutics's price target?

MiNK Therapeutics's price target, set by 5 Wall Street analysts, averages $35 over the next 12 months. The price target range spans from $35 at the low end to $35 at the high end, suggesting a potential 146.48% change from the previous closing price of $14.2.

How does MiNK Therapeutics stock forecast compare to its benchmarks?

MiNK Therapeutics's stock forecast shows a 146.48% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for MiNK Therapeutics over the past three months?

  • October 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is MiNK Therapeutics’s EPS forecast?

MiNK Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.71, marking a -99.05% decrease from the reported $-286 in 2024. Estimates for the following years are $-2.86 in 2026, $-2.7 in 2027, and $2.4 in 2028.

What is MiNK Therapeutics’s revenue forecast?

MiNK Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $4.4M for 2027, and $70.4M for 2028.

What is MiNK Therapeutics’s net income forecast?

MiNK Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-93.173M, representing a -99.14% decrease from the reported $-10.785B in 2024. Projections indicate $-98.184M in 2026, $-92.772M in 2027, and $82.46M in 2028.